IDH mutation analysis is now a prerequisite for diagnosing an Astrocytoma, and research shows that these mutations appear to confer a significant survival advantage over their wild-type counterparts [5-9]. This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).